|1.||Marina, M: 1 article (08/2009)|
|2.||Kantardjiev, T: 1 article (08/2009)|
|3.||Ivanova, M: 1 article (08/2009)|
|4.||Ramos, María Julia Couto: 1 article (11/2004)|
|5.||Hernández, María Espino: 1 article (11/2004)|
|6.||Ferrer, Niurka Fiol: 1 article (11/2004)|
|7.||Derevianko, I I: 1 article (07/2001)|
|8.||Prudnikova, S A: 1 article (07/2001)|
|9.||Lavrinova, L N: 1 article (07/2001)|
|10.||Nefedova, L A: 1 article (07/2001)|
05/01/1983 - "Azlocillin was effective for treating serious infections caused primarily by Ps. "
05/01/1983 - "Azlocillin was a safe and effective antimicrobial agent for the treatment of serious infections caused by strains of Pseudomonas sp., primarily Ps. "
11/01/1985 - "The antibacterial efficacy of azlocillin against Pseudomonas aeruginosa was quantitatively assessed in short-term growth curves in vitro and in a short-term thigh muscle infection in granulocytopenic mice. "
03/29/1984 - "This study suggests that azlocillin is of value in the treatment of bronchopulmonary infections caused by Ps. "
08/01/1987 - "Their results show that azlocillin alone is potent enough to be used in the treatment of severe infections."
09/15/1988 - "[Treatment of infectious endocarditis with azlocillin]."
01/01/1989 - "Efficacy of ciprofloxacin alone and in combination with azlocillin in experimental endocarditis due to Pseudomonas aeruginosa."
09/01/1985 - "The efficacy of ciprofloxacin (Bay o 9867), a promising new quinolone, was compared with the efficacy of azlocillin plus tobramycin in rabbits with experimentally induced Pseudomonas aeruginosa endocarditis. "
01/01/1989 - "The efficacy of ciprofloxacin alone and in combination with azlocillin was compared with that of azlocillin plus tobramycin in a rat model of aortic valve endocarditis due to Pseudomonas aeruginosa. "
05/01/1986 - "The efficacy of ciprofloxacin and netilmicin + azlocillin has been studied in 79 rabbits with aortic valve endocarditis caused by a serum-resistant strain of P. "
|3.||Cystic Fibrosis (Mucoviscidosis)
11/01/1985 - "Patients with cystic fibrosis appear to eliminate azlocillin more rapidly than healthy individuals. "
05/01/1984 - "The pharmacokinetic analysis offers further evidence of the dose-dependent nature of azlocillin elimination, but elimination did not appear to be altered in cystic fibrosis patients."
05/01/1984 - "The pharmacokinetics of azlocillin were studied in 10 cystic fibrosis patients, ranging in age from 11 to 28 years. "
05/01/1984 - "Azlocillin pharmacokinetics in patients with cystic fibrosis."
11/01/1983 - "Azlocillin in cystic fibrosis."
|4.||Urinary Tract Infections (Urinary Tract Infection)
01/01/1988 - "Examining serum level values and urinary concentrations taken from non-pregnant control persons and pregnant women suffering from urinary tract infections (UTI) during the III. trimenon, the pharmacokinetic dates after single and repeated applications of 4 g azlocillin have been evaluated. "
03/29/1984 - "Ten cases of urinary tract infection (6 acute and 3 relapsing) treated with azlocillin are reported. "
01/01/1982 - "Clinical experience with azlocillin in the treatment of urinary tract infections with Pseudomonas aeruginosa."
01/01/1981 - "Preoperative treatment with azlocillin in complicated urinary tract infections."
01/01/1981 - "All patients were treated for urinary tract infections with azlocillin 2 g three times daily for a period of ten days. "
03/29/1984 - "[Monotherapy of Pseudomonas aeruginosa septicemia with azlocillin]."
11/01/2004 - "[Azlocillin plus amikacin: an alternative therapy for sepsis caused by resistant staphylococci?]."
01/01/1986 - "Control of Pseudomonas sepsis in mice with azlocillin combined with gentamicin."
11/01/2004 - "To assess the effectiveness of combined therapy with azlocillin and amikacin in a group of neonates with sepsis caused by multiresistant staphylococci who were hospitalized in the neonatal intensive care unit of Hospital Ginecobstétrico "America Arias" in Havana, Cuba, from 1998 to 2000. "
04/01/1987 - "Comparative efficacy of ciprofloxacin, azlocillin, and tobramycin alone and in combination in experimental Pseudomonas sepsis."
|6.||Anti-Bacterial Agents (Antibiotics)
|1.||Drug Therapy (Chemotherapy)
|3.||Intensive Care (Surgical Intensive Care)
|4.||Neonatal Intensive Care
|5.||Continuous Ambulatory Peritoneal Dialysis (CAPD)